Melanogenesis, Its Regulatory Process, and Insights on Biomedical, Biotechnological, and Pharmacological Potentials of Melanin as Antiviral Biochemical by Fatoki, Toluwase Hezekiah et al.
Tennessee State University 
Digital Scholarship @ Tennessee State University 
Chemistry Student Research Department of Chemistry 
12-22-2020 
Melanogenesis, Its Regulatory Process, and Insights on 
Biomedical, Biotechnological, and Pharmacological Potentials of 
Melanin as Antiviral Biochemical 
Toluwase Hezekiah Fatoki 
Omodele Ibraheem 
Catherine Joke Adeseko 
Boluwatife Lawrence Afolabi 
Daniel Uwaremhevho Momodu 
See next page for additional authors 
Follow this and additional works at: https://digitalscholarship.tnstate.edu/chemistry-students 
 Part of the Medicinal-Pharmaceutical Chemistry Commons, Organic Chemistry Commons, and the 
Pharmacology Commons 
Authors 
Toluwase Hezekiah Fatoki, Omodele Ibraheem, Catherine Joke Adeseko, Boluwatife Lawrence Afolabi, 
Daniel Uwaremhevho Momodu, David Morakinyo Sanni, Jesupemi Mercy Enibukun, Ibukun Oladejo 
Ogunyemi, Akinwunmi Oluwaseun Adeoye, Harriet U. Ugboko, Amoge Chidinma Ogu, Abiodun Samuel 
Oyedele, Adejoju Omodolapo Adedara, Abiodun Joseph Jimoh, Oluwakemi Ruth Ogundana, and 
Oritsetimeyin Eworitse Ebosa 
 
 https://biointerfaceresearch.com/  11969 
Review 
Volume 11, Issue 4, 2021, 11969 - 11984 
https://doi.org/10.33263/BRIAC114.1196911984 
 
Melanogenesis, Its Regulatory Process, and Insights on 
Biomedical, Biotechnological, and Pharmacological 
Potentials of Melanin as Antiviral Biochemical 
Toluwase Hezekiah Fatoki 1,* , Omodele Ibraheem 1 , Catherine Joke Adeseko 2 , Boluwatife 
Lawrence Afolabi 3 , Daniel Uwaremhevho Momodu 4 , David Morakinyo Sanni 2 , Jesupemi Mercy                       
Enibukun 5 , Ibukun Oladejo Ogunyemi 6 , Akinwunmi Oluwaseun Adeoye 1 , Harriet U. Ugboko 7
, Amoge Chidinma Ogu 8 , Abiodun Samuel Oyedele 9 , Adejoju Omodolapo Adedara 10 , Abiodun 
Joseph Jimoh 11 , Oluwakemi Ruth Ogundana 2 , Oritsetimeyin Eworitse Ebosa 12  
1 Department of Biochemistry, Federal University Oye, PMB 373 Oye-Ekiti, Ekiti State, Nigeria; 
hezekiahfatoki@gmail.com (T.H.F.); deleibraheem2007@yahoo.com (O.I.); akinwunmi.adeoye@fuoye.edu.ng (A.O.A.); 
2 Department of Biochemistry, Federal University of Technology, PMB 704, Akure, Ondo State, Nigeria; 
catherineadeseko@gmail.com (C.J.A.); dmsanni@futa.edu.ng (D.M.S.); chosenkemmy@gmail.com (O.R.O); 
3 Department of Biochemistry, Federal University of Technology, Minna, Niger State, Nigeria; bolu.afolabi@gmail.com 
(B.L.A.); 
4 Department of Chemistry, Federal University Oye, PMB 373 Oye-Ekiti, Ekiti State, Nigeria; 
daniel.momodu@fuoye.edu.ng (D.U.M); 
5 Department of Microbiology, Federal University of Technology, PMB 704, Akure, Ondo State, Nigeria; 
jesupemienibukun@gmail.com (J.M.E.); 
6 Department of Nutrition and Biomedicine, Technical University of Munich, Germany; ogunyemiibukun@gmail.com 
(I.O.O.); 
7 Microbiology Research Unit, Department of Biological Sciences, Covenant University, Ota, Ogun State, Nigeria; 
harrietugboko@gmail.com (H.U.U.); 
8 Department of Medical Biotechnology, National Biotechnology Development Agency, Lugbe, PMB 5118 Wuse Zone 3, 
Abuja, FCT, Nigeria; amosmeks@gmail.com (A.C.O); 
9 Department of Chemistry, Tennessee State University, Nashville, TN 37209-1561, USA; oyedeleabey12@gmail.com 
(A.S.O.); 
10 Department of Chemistry, Federal University of Technology, PMB 704, Akure, Nigeria; adejojubadiru@gmail.com 
(A.O.A.); 
11 Department of Biology, Federal University of Technology, PMB 704, Akure, Nigeria; jimohabiodun73@gmail.com 
(A.J.J); 
12 Department of Microbiology, Babcock University, Ilishan-Remo, Ogun State, Nigeria;  otimeyinebosa15@gmail.com 
(O.E.B.); 
* Correspondence: toluwase.fatoki@fuoye.edu.ng;  
Scopus Author ID 57211491082 
Received: 30.10.2020; Revised: 15.12.2020; Accepted: 18.12.2020; Published: 22.12.2020 
Abstract: Melanin is s most widely distributed pigment and is found in bacteria, fungi, plants, and 
animals. Melanogenesis is under complex regulatory control by multiple agents interacting through 
pathways activated by hormonal and receptor-dependent and -independent mechanisms. There are 
about 20 genes that are involved in the biochemical pathway of melanogenesis and its regulation, which 
include: tyrosinase, microphthalmia-associated transcription factor, melanocortin1 receptor, adenylate 
cyclase, protein kinase A. Human melanogenesis regulatory proteins such as MAPK1, CREB3, and 
CREBP, have binary interaction with the protein of herpesvirus, hepatitis C virus, Human 
immunodeficiency virus type 1, Simian virus 40, and Human adenovirus A and C. Melanin is a double-
edged sword in host-pathogen interaction (e.g., human-bacteria and/or fungi interaction). The inducers 
of upregulation of melanogenesis include fluvoxamine, famotidine, terbutaline, heliotrine, sirolimus, 
dicoumarol, Prestwick-860, carbimazole, (-)-MK-801, rilmenidine, hydrastine hydrochloride, 
haloperidol, scopolamine N-oxide, raubasine, and dihydroergocristine. In melanogenesis, GSK3B, 
CSNK2A, MAPK1, MAPK3, MAPK14, ERK1, and HIPK2 were the major kinases, while RUNX1, 
GATA1, and REST, SUN12, and RCOR1 were the major transcription factors. This study has reviewed 
the melanogenesis pathway, its regulations as well as applications to viral infection. The antiviral 
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activity of melanin and its complex in the presence of antibacterial and antifungal compounds should 
be investigated to further provide insight for biomedical, biotechnological, and pharmacological 
applications. 
Keywords: melanin; melanogenesis; regulation; biomedical; biotechnological; pharmaceutical; 
antiviral; melatonin. 
© 2020 by the authors. This article is an open-access article distributed under the terms and conditions of the Creative 
Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). 
1. Introduction 
Melanins, the end-products of L-tyrosine complex multistep transformations, are 
polymorphous and multifunctional biopolymers [1]. Melanin is a widely distributed pigment 
and is found in bacteria, fungi, plants, and animals. In animals, it is secreted by melanocyte 
cells distributed in the basal layer of the dermis [2]. Melanins are majorly insoluble and 
naturally consist of four types; allomelanin, eumelanin, neuromelanin, and pheomelanin [3]. It 
is a heterogeneous, polyphenol-like biopolymer with a complex structure and color varying 
from yellow to black, namely allomelanin in plants and fungi, neuromelanin, pheomelanin, and 
eumelanin in human [4]. A study has determined that eumelanin is more resistant than 
pheomelanin towards UV-Vis radiation [5]. Melanin is a radical-free polymer presenting a 
highly-conjugated structure that enables the transformation of UV-Vis radiation into heat [6]. 
Basophils, mast cells, and eosinophils are important in the viral microenvironment, 
contributing majorly to viral growth, as well as tumor and cancer proliferation [7].  Eumelanin 
inhibits the proliferation of mast cells in disease involving immune cells [8]. Melanins have 
multifunctional biological properties such as antioxidant, anti-inflammatory, radioprotective, 
antimicrobial, metal chelation, radical scavenger, chemoprotective, and antiviral property              
[9-12]. 
2. Melanogenesis and it's Regulation  
Melanogenesis is under complex regulatory control by multiple agents interacting 
through pathways activated by receptor-dependent and -independent mechanisms, in 
hormonal, auto-, para-, or intracrine manner [1]. The control of melanogenesis is an important 
strategy in treating abnormal skin pigmentation for cosmetic purposes [13]. Melanin synthesis 
(as shown in Figure 1) is mainly controlled by tyrosinase, a copper-containing enzyme that 
catalyzes two distinct reactions in melanin synthesis, viz the hydroxylation of tyrosine by 
monophenolase action and the oxidation of 3,4-dihydroxy-L-phenylalanine (L-DOPA) to o-
dopaquinone by diphenolase action [14]. o-Dopaquinone is unstable in an aqueous solution and 
rapidly suffers a non-enzymatic cyclization to leukodopachrome, which is further oxidized 
non-enzymatically by another molecule of o-dopaquinone to yield dopachrome and one 
molecule of regenerated L-DOPA [15]. Although the Raper-Mason pathway and its neuronal 
or insect variants are the routes for the synthesis of animal melanins, the biosynthesis of 
allomelanins in lower organisms occur from precursor different from L-tyrosine which are 
catechols in plants, and 1,8-dihydroxynaphthalene in fungi [16]. Under physiological 
conditions, melanin synthesis in melanocytes is restricted to melanosomes. Melanosomes 
contain a proton pump that allows regulation of intra-melanosomal pH. It also internalizes cell 
surface melanocyte-stimulating hormone (MSH) receptors via the endocytic pathway [17]. 
Unlike animal melanocytes, where melanin is located almost exclusively within melanosomes 
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(as shown in Figure 2), fungal and bacterial melanin can be formed in intracellular and/or 
extracellular spaces in insects, plants, and many bacterial species, where the enzyme and/or the 
precursors are secreted to give place to melanogenesis for defensive purposes, as for hardening 
exocuticle, cell walls, and even neutralizing host defenses in pathogenic species [16]. 
 
Figure 1. Raper-Mason pathway for eu- and pheomelanin formation. Adapted from Solano [16]. 
Melanogenesis is a complex process that is regulated by many genes [18]. According 
to Pahari et al. [19], the genes that are involved in the biochemical pathway of melanogenesis 
and its regulation include: Microphthalmia Associated Transcription Factor (MITF), Paired 
box gene 3 (PAX3), Melanocortin1 receptor (MC1R), Adenylate Cyclase (AC), Protein Kinase 
A (PKA), Beta-catenin (β-Catenin), Tyrosine kinase receptor (C-kit), Ras GTPase protein 
(RAS), RAF kinase protein (RAF), Mitogen-activated protein kinase (MEK), Extracellular 
signal-Regulated Kinase (ERK), Tyrosinase (TYR), Tyrosinase Related Protein 1 and 2 
(TYRP1 and TYRP2). Other possible regulators of melanogenesis that remain to be 
characterized and cloned include dihydroxyindole (DHI) inhibitory factor, which decreases the 
rate of DHI transformation to melanin, and stablin, which prevents autoxidation of DHI 
carboxylic acid (DHICA) to melanin [1]. 
D’Mello et al. [20] have explained that eumelanin and pheomelanin are synthesized 
within melanosomes of melanocytes by a series of reactions that are catalyzed by specific 
melanogenic enzymes whose production is driven by the MITF. The activity of MITF drives 
the expression of a number of genes (including SOX10 and PAX3) and is regulated by a 
number of signaling pathways,including Protein kinase C (PKC); cyclic AMP (cAMP); 
MAPK/ERK Kinase (MEK); Wingless-related integration site (WNT). These signaling 
pathways are activated upstream by receptors such as tyrosine kinase receptor KIT (ligand: 
Stem Cell Factor (SCF)) and Melanocyte-specific melanocortin-1 receptor (MC1R) (ligands: 
αmelanocyte-stimulating hormone (α-MSH); adrenocorticotropic hormone (ACTH); agonist 
stimulating protein (ASP)). According to Guyton and Hall [22], a preprohormone called 
proopiomelanocortin (POMC) is the precursor of adrenocorticotropic hormone (ACTH) as well 
as several other peptides, including melanocyte-stimulating hormone (MSH), β-lipotropin, β-
endorphin, and a few others. α-Melanocyte stimulating hormone (α-MSH) is a 13-residue 
peptide that stimulates the release of melanin by skin melanocytes.α-MSH also binds to the 
melanocortin 4 receptor (MC4R), modulating food intake and energy utilization [23]. It has 
been reported that transcription factors such as lymphoid-enhancing factor-1 are involved in 
the expression of tyrosinase-related proteins such as TRP-1 and TRP-2 [24]. Moreover, another 
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transcription factor called the microphthalmia-associated transcription factor (MITF), played a 
key role in melanocyte survival, development, and differentiation [25]. 
 
Figure 2. Melanogenesis pathway, showing regulatory elements and tyrosine metabolism leading to melanin [21]. 
Reprinted with permission. 
However, tyrosinase plays a critical regulatory role in melanin biosynthesis. The 
activation of MITF, a transcription factor that regulates tyrosinase gene expression, is a critical 
event during melanogenesis [26,27]. During the melanogenesis in melanocytes, the ERK 
cascade depresses MITF protein stability in the nucleus [26-30]. Moreover, ascorbic acid plays 
an important role (significantly enhanced) in the ERK pathway in α-MSH-induced B16 
melanoma cells [31]. The mechanism of cAMP regulation of melanogenesis involves the 
activation of protein kinase A (PKA), which then phosphorylates enzymes, ion channels, and 
several regulatory proteins [1]. The transcriptional control of melanogenesis by cAMP is 
coordinated predominantly by MITF. Besides, activation of ras oncogene inhibits 
melanogenesis in normal and malignant melanocytes [32,33]. Another signal transduction 
pathway important in regulating melanogenesis is represented by protein kinase C (PKC) [34-
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36]. Moreover, it has been reported that angiotensin II stimulates melanogenesis via the protein 
kinase C pathway [37]. 
3. Melanin and Melanogenesis Interactions with Virus Proteins and Melatonin  
3.1. Melanogenesis regulatory proteins interact and modulate specific virus proteins. 
Based on curated data on UniProt database (ref.: www.uniprot.org), catenin beta-1 
(CTNNB1) interacts with herpes virus 8 protein vPK; and this interaction inhibits the Wnt 
signaling pathway. Mitogen-activated protein kinase 1 (MAPK1) interacts with HIV-1 Nef 
through its SH3 domain. CREB-binding protein (CREBBP) interacts with HTLV-1 Tax, p30II, 
and HBZ; human herpesvirus 8/HHV-8 protein vIRF-1; and HIV-1 Tat. Cyclic AMP-
responsive element-binding protein 3 (CREB3) plays a role in virus protein expression in 
human immunodeficiency virus type 1 (HIV-1). It also plays a role in herpes simplex virus-1 
(HSV-1) latent infection and reactivation from latency; where it represses the VP16-mediated 
transactivation of immediate early genes of the HSV-1 virus by sequestering host cell factor-1 
(HCFC1) in the endoplasmic reticulum (ER) membrane of sensory neurons, thereby preventing 
the initiation of the replicative cascade leading to latent infection. It activates the transcription 
of genes required for reactivation of the latent HSV-1 virus. CREB3 may play a role as a 
cellular tumor suppressor that is targeted by the hepatitis C virus (HCV) core protein, and 
CREBZF inhibits its transcriptional activity in an HCFC1-dependent manner by the viral 
transactivator HCV core protein. 
Moreover, Human MAPK1 shows binary interaction with a protein (Uniport ID: 
Q69559) from Human herpesvirus 6A (strain Uganda-1102). Human CREB3 shows binary 
interaction with a protein (Uniport ID: P29846) from Hepatitis C virus genotype 1b (isolate 
Taiwan). Human CREBBP show binary interactions with several proteins, which include 
protein (Uniport ID: P04608) from Human immunodeficiency virus type 1 group M subtype B 
(isolate HXB2); protein (Uniport ID: P03070) from Simian virus 40 (SV40); protein (Uniport 
ID: P03255) from Human adenovirus (HAV) C serotype 5; and protein (Uniport ID: P03259) 
from Human adenovirus A serotype 12. A study has shown that L-DOPA is active against a 
Simian immunodeficiency virus, exhibiting selective and restricted antiviral activity [12]. 
3.2. Melatonin Interaction with melanogenesis. 
Melatonin (N-acetyl-5-methoxytryptamine) controls the changes in pigmentation by 
aggregating melanin into the melanocytes within the skin. Sunlight suppresses the secretion of 
melatonin, and increases the secretion of melanocyte-stimulating hormone (MSH), which 
suppresses TH1 cell activity [38], and stimulates the release of melanin by the skin melanocytes. 
α-Melanocyte-stimulating hormone (α-MSH) decreases feeding (anorexigenic), whereas 
melanin-concentrating hormone (MCH) increase feeding (orexigenic) in the hypothalamus 
[22]. According to Slominski and Pruski [39], melatonin has antagonistic activity against 
melanogenesis inducers (L-tyrosine or MSH). Melatonin and MSH are potential inhibitors of 
tyrosine-protein kinase receptor and dopamine/histamine H2 receptor, respectively. These 
receptors could be essential for coronavirus (SARS-CoV-2) virulence by indirectly interact 
with several SARS-CoV-2 cellular targets such as ACE2, BCL2L1, JUN, and IKBKB [40, 41].  
Unlike melanin, melatonin synthesis occurs in pinealocytes from tryptophan at night-
time (absence of sunlight) [42]. The protective effects of melatonin against viral infection such 
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as encephalomyocarditis virus, Semliki Forest virus, West Nile virus ad respiratory syncytial 
virus have been studied [43]. T-lymphocytes, natural killer (NK) cells, eosinophils, and mast 
cells possess melatonin receptors [44]. Eumelanin inhibits the proliferation of mast cells in 
disease involving immune cells [8]. Microscopically, there was no definite evidence that 
melatonin caused the melanin granules within the melanocytes to change their position. The 
length and complexity of the melanocytes' dendritic processes remained unaltered in most of 
the animals [44]. Melatonin administration increases the proliferative response of rat 
lymphocytes, increases the number of NK cells, stimulates the release of pro-inflammatory 
cytokines interleukin (IL)-1 and tumor necrosis factor (TNF)-α, enhances phagocytosis and 
modulates apoptosis [43]. In contrast, melanin showed inhibitory effects on these 
immunological biomarkers [45, 46]. Thus, it could be hypothesized that melatonin responds 
against virus infection that downregulates immunological biomarkers, while melanin responds 
against virus infection that upregulates immunological biomarkers. This understanding will 
help in clinical diagnosis in biomedicine and pave the way for antiviral agents' 
biopharmaceutics development. Melatonin synthesis depends on the induction of adrenergic 
signal transduction. It is a cross-section with melanin synthesis via the cAMP-PKA-CREB-
CRE pathway (see Figure 2) [42]. 
4. Antiviral Applications of Melanin and Melanogenesis 
The study of melanin and melanogenesis have found applications in pharmaceutical, 
biomedical, and biotechnological fields. Inhibition of melanin synthesis is sometimes a 
desirable process for several purposes, mainly for cosmetical reasons in human skin, for anti-
browning treatments in fruit technology, and for diminishing some pathogenic fungi' virulence 
and bacteria [16]. Melanin is a double-edged sword in host-pathogen interaction (e.g., human-
bacteria and/or fungi interaction), as these organisms (host and pathogen) synthesize melanin 
with antagonist purposes; host melanin is a defense against the pathogen infection, and 
microbial melanin is a defense against the oxidative attack and release of reactive oxygen 
species from the host [16]. 
4.1. Biomedical application.  
Biomedically, melanin may play a role in regulating the activity of immunological 
cytokines. A study has shown that melanocytes produce numerous immunological biomarkers, 
including interleukin 1 (IL-1) and IL-6 [45]. Also, a study has shown that synthetically derived 
melanin at non-cytotoxic concentrations reversibly suppressed the production of tumor 
necrosis factor (TNF), inhibited the production of interleukins IL-1b, IL-6, and IL-10 by 
lipopolysaccharide (LPS) stimulated monocytes [46], inhibited macrophage migration 
inhibitory factor (MIF) which possesses oxidoreductase (tyrosinase-like) activity necessary for 
the formation of neuromelanin precursors [47]. The interferons (IFN) consist of a large family 
of antiviral peptides. IFN-β mRNA is rarely expressed in melanoma cells and suppresses the 
proliferation of melanoma cells [48].  
Polyinosinic-polycytidylic acid (poly(I:C)), is a synthetic analog of double-stranded 
RNA synthesized by various types of viruses.  γδ T-cell activation by immunostimulatory 
double-stranded RNA, such as poly(I:C), is indirectly mediated via type I interferons (IFN-α, 
IFN-β) and may contribute to effective antiviral responses in human [49]. Poly(I:C) induces 
IFN-β mRNA, and it is an agonist of toll-like receptor (TLR) 3 and retinoic acid-inducible gene 
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I (RIG-I)-like receptors (RLRs), including RIG-I and melanoma differentiation-associated 
gene 5 (MDA5). The activation of TLR3 and RLR signaling by poly(I:C) can directly trigger 
apoptosis in some cancer cells [50]. According to Blalock and Harp [51], adrenocorticotropic 
hormone (ACTH) and human but not mouse interferon caused induction of melanin synthesis 
and antiviral activity in human melanoma cells. Thus, interferon has species-specific hormonal 
activity, and ACTH has cell-specific antiviral activity. The natural function of interferon is 
hormonal, and that of hormones includes the protection of tissues against viruses. 
The enzyme cascade, which leads to melanin, the prophenoloxidase-activating system, 
forms the central antimicrobial defense system in many animals. Most melanins exist in an 
insoluble form, but synthetic soluble melanins have been shown to inhibit the replication of 
human immunodeficiency virus types 1 and 2 (HIV-1 and HIV-2) in two human 
lymphoblastoid cell lines (MT-2 and H9) and phytohemagglutinin-stimulated human T cells, 
as well as blocked the HIV-1 envelope surface glycoprotein, and T cell-specific monoclonal 
antibody leu-3a (CD4+), with no effect on HIV-1 reverse transcriptase activity in viral lysates 
[12,52].  
It has been reported that skin darkness due to melanins and melanocytes have a vital 
role in defending against infectious disease [53]. The skin darkness was negatively associated 
with rates of HIV infection in sub-Saharan Africa. This relationship was attributed to possible 
lower infection rates of other parasites, especially bacteria and fungi, that lead to tissue damage 
in the genital tract and hence increased the chance for contracting HIV [54]. Melanin 
production directly favors bacterial and fungal infections but not a viral infection. A bacterial 
and fungal infection could serve as a template for viral infection but not vice versa. The 
production process of melanin may protect bacteria and fungi such as Bacteroides 
melaninogenicus (recently renamed as Prevotella melaninogenica) Sporothrix schenckii, and 
Cryptococci from the oxidative injury of phagocytes. The melanin pigments are produced in 
Cryptococcus neoformans, where it played a role in its virulence [55,56]. Melanisation often 
becomes a virulence factor in some pathogenic bacteria because melanin protects bacterial cells 
from a defense mechanism in the infected host [57]. 
In Streptomyces, melanin formation is a protective response to adverse environmental 
conditions [58]. Bacillus thuringiensis synthesizes melanin that protects against pesticides [59]. 
Melanin is inherent in the tropical region, especially in populations of Africans, Asians, 
Hispanics, etc. Mosquito is an agent that transmit many human viruses such as Chikungunya 
virus (CV), Dengue virus (DV), Japanese encephalitis virus (JEV), and West Nile virus 
(WNV), and its antiviral mechanism has been linked to the gene Prophenoloxidase (PPO), 
encoding a prototype of phenoloxidase, which is predominantly expressed in mosquito 
hemocytes [60]. Melanization in Lepidoptera hemolymph mediates antiviral activity during 
infection with Microplitis demolitor bracovirus [61]. A study has shown that melanin produced 
by a Pseudomonas balearica strain possessed antimicrobial activity against phytopathogenic 
strains, which include Erwina carotovora and Erwina chrysanthemi, as well as against Candida 
albicans, Escherichia coli, and Staphylococcus aureus [62]. 
The pigmentary effects of small oligonucleotides, which involved amplifying the 
melanogenic effect of α-MSH [35,63], could follow a pathway functionally similar to the SOS 
response system of bacteria [63]. The SOS response involves the induction of several proteins 
that serve to enhance the integrity of DNA through complex regulation. It includes error-prone 
factors that allow for improved survival and continuous replication in the presence of extensive 
DNA damage but at the cost of elevated mutagenesis [64]. Melanogenesis and its intermediates 
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can switch cell metabolism from aerobic to anaerobic glycolysis, stimulate the pentose 
phosphate pathway, and/or inhibit glycoprotein phosphorylation [1]. Melanin and melanin-like 
nanoparticles have found application in both biomedical and biotechnological fields [65,66].  
4.2. Biotechnological application. 
In biotechnology, microbial infection such as viral, bacterial, and fungal challenge can 
induce PPO activity. According to Escobar et al. [67], protective effects of polyphenol oxidase 
(PPO) have generally been attributed to the generation of reactive quinones, which may 1) 
possess direct bacteriocidal/insecticidal properties; 2) generate toxic reactive oxygen species 
through secondary oxidation reactions; 3) reduce protein palatability and digestibility by 
oxidizing nucleophilic amino acids; and 4) form an impermeable melanin barrier, preventing 
the spread of pathogen infection. In-plant infection, fungal melanin has a different particular 
function as the pigment is essential for cell wall penetration in appressorial processes [68,69]. 
PPO-overexpressing tomatoes display enhanced resistance to the bacterial pathogen 
Pseudomonas syringae pv. tomato [70]. Thang et al. [71] have reported that melanin-containing 
diets may be applied in aquaculture to protect shrimp against white spot syndrome virus 
infection. 
4.3. Pharmacological application. 
In pharmacology, microbial tyrosinase is used to produce synthetic melanin, which 
protects against radiation and is used as cation exchangers, drug carriers, antioxidants, antiviral 
agents, or immunogens [72]. Significant antiviral activity has been observed in the synthesis 
of lipophilic catechols by tyrosinase, suggesting a new inhibition mechanism based on both 
redox and lipophilic properties [73]. L-DOPA inhibits in vitro phosphorylation of melanoma 
glycoproteins [74]. Diacylglycerol (an endogenous activator of PKC) can stimulate melanin 
synthesis both in cell culture and in vivo [75,76]. At the same time, melanogenesis could be 
blocked by PKC inhibitors or cellular depletion of PKC [35,36]. It has been reported that an 
aqueous solution of melanin and melanin-glucan complex derived from Chaga fungus Inonotus 
obliquus have antiviral activity against HSV-2 and HIV-1 [77]. 
Ellagic acid interferes with the melanin biogenesis pathway [78]. Ellagic acid 
(DB08846) is an inhibitor of human PRKCA (UniProt ID: P17252) and PRKCB proteins 
(UniProt ID: P05771). Ito and Wakamatsu [79] reported that ellagic acid could act as an 
alternative tyrosinase substrate to be oxidized to form o-quinones. Semiquinones may then 
react with nucleophilic compounds. High doses or long exposure of melanin-containing cells 
such as eyes and skin to chloroquine can cause toxicity of the skin, blood, and eyes. It becomes 
concentrated in melanin-containing structures, which can lead to corneal deposits and blindness 
[80]. However, ellagic acid has been reported for antiviral activity against a spectrum of 
viruses, including coronavirus [40]. A study has shown that Liquiritin (LQ) and liquiritigenin 
(LQG), which are the major flavonoids in licorice root (Glycyrrhiza spp.), induced 
melanogenesis (the expression of tyrosinase, TRP-1, and TRP-2; MITF, and CREB protein 
phosphorylation), through enhancement of p38 and PKA signaling pathway [81]. Also, 
inhibition of C‑terminal Src kinase induced melanogenesis by phosphorylation of p38 mitogen-
activated protein kinase (MAPK) and CREB pathways in human G361 cells [82]. 
Melanogenesis regulatory proteins and their associated pathologies due to mutation are 
shown in Table 1. Another study has provided a review of these pathologies [18]. Based on 
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Figure 2, twenty (20) genes involved in the regulation of melanogenesis, as shown in Table 1, 
were obtained from the UniProt database.  The transcription factors and kinases associated with 
the 20 genes were analyzed and visualized on the eXpression2Kinases webserver at default 
setting [83] as shown in Figure 3. The top 15 drugs that can induce and reverse the up-
regulation and down-regulation of these melanogenesis regulatory proteins was predicted on 
Expression2Kinases software, at a default setting using human as an organism of interest [84] 
as shown in Table 2. In melanogenesis, GSK3B, CSNK2A, MAPK1, MAPK3, MAPK14, 
ERK1, and HIPK2 were the major kinases, while RUNX1, GATA1, and REST, SUN12, and 
RCOR1 were the major transcription factors. 
Table 1. Melanogenesis regulatory proteins and their associated pathologies due to mutation. 
S.N. Regulatory Protein  Gene UniProt 
ID 
Pathology Due To Mutation 
(https://www.orpha.net/) 
1 Adenylate cyclase type 1 ADCY1 Q08828 90636, Autosomal recessive non-syndromic sensorineural 
deafness type DFNB  
2 Calcium/calmodulin-
dependent protein kinase 
type II subunit alpha 




dependent protein kinase 
type II subunit gamma 
CAMK2G Q13555 - 
4 Catenin beta-1 CTNNB1 P35222 210159, Adult hepatocellular carcinoma;  
54595, Craniopharyngioma; 
873, Desmoid tumor; 
891, Familial exudative vitreoretinopathy; 
85142, Aldosterone-producing adenoma; 
33402, Pediatric hepatocellular carcinoma; 
91414, Pilomatrixoma; 
404473, Severe intellectual disability-progressive spastic 
diplegia syndrome 
5 L-dopachrome tautomerase DCT P40126 - 
6 Endothelin receptor type B EDNRB P24530 388, Hirschsprung disease; 
895, Waardenburg syndrome type 2; 
897, Waardenburg-Shah syndrome 
7 Frizzled-4 FZD4 Q9ULV1 891, Familial exudative vitreoretinopathy; 
91495, Persistent hyperplastic primary vitreous; 
90050, Retinopathy of prematurity 
8 Mast/stem cell growth factor 
receptor Kit 
KIT P10721 98834, Acute myeloblastic leukemia with maturation; 
98829, Acute myeloid leukemia with abnormal bone 
marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22); 
102724, Acute myeloid leukemia with t(8;21)(q22;q22) 
translocation; 
280785, Bullous diffuse cutaneous mastocytosis; 
79455, Cutaneous mastocytoma; 
44890, Gastrointestinal stromal tumor; 
158778, Isolated bone marrow mastocytosis; 
158772, Nodular urticaria pigmentosa; 
2884, Piebaldism; 
158769, Plaque-form urticaria pigmentosa; 
280794, Pseudoxanthomatous diffuse cutaneous 
mastocytosis; 
544260, Selection of therapeutic option in melanoma; 
158775, Smoldering systemic mastocytosis; 
98849, Systemic mastocytosis with associated hematologic 
neoplasm; 
90389, Telangiectasia macularis eruptiva perstans; 
842, Testicular seminomatous germ cell tumor; 
158766, Typical urticaria pigmentosa 
9 Melanocyte-stimulating 
hormone receptor 
MC1R Q01726 618, Familial melanoma; 
626, Large congenital melanocytic nevus; 
79432, Oculocutaneous albinism type 2 
10 Microphthalmia-associated 
transcription factor 
MITF O75030 404511, Clear cell papillary renal cell carcinoma; 
618, Familial melanoma; 
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S.N. Regulatory Protein  Gene UniProt 
ID 
Pathology Due To Mutation 
(https://www.orpha.net/) 
293822, MITF-related melanoma and renal cell carcinoma 
predisposition syndrome; 
352740, Ocular albinism with congenital sensorineural 
deafness; 
319298, Papillary renal cell carcinoma; 
42665, Tietz syndrome; 
895, Waardenburg syndrome type 2; 
897, Waardenburg-Shah syndrome 
11 cAMP-dependent protein 
kinase catalytic subunit 
alpha 
PRKACA P17612 401920, Fibrolamellar hepatocellular carcinoma; 
189439, Primary pigmented nodular adrenocortical disease 
12 Protein kinase C alpha type PRKCA P17252 - 
13 Protein kinase C beta type PRKCB P05771 - 
14 Tyrosinase TYR P14679 352734, Minimal pigment oculocutaneous albinism type 1; 
352740, Ocular albinism with congenital sensorineural 
deafness; 
79431, Oculocutaneous albinism type 1A; 
79434, Oculocutaneous albinism type 1B; 
352737, Temperature-sensitive oculocutaneous albinism 
type 1 
15 5,6-dihydroxyindole-2-
carboxylic acid oxidase 




PLCB1 Q9NQ66 293181, Malignant migrating focal seizures of infancy; 
3451, West syndrome 
17 Mitogen-activated protein 
kinase 1 
MAPK1 P28482 261330, Distal 22q11.2 microdeletion syndrome 
18 Transcription factor 7 TCF7 P36402 - 
19 CREB-binding protein CREBBP Q92793 370026, Acute myeloid leukemia with t(8;16)(p11;p13) 
translocation; 
353281, Rubinstein-Taybi syndrome due to 16p13.3 
microdeletion; 
353277, Rubinstein-Taybi syndrome due to CREBBP 
mutations 
20 Cyclic AMP-responsive 
element-binding protein 3 
CREB3 O43889 - 
 
Figure 3. Network expression of transcription factors and kinases associated with 20 regulatory genes of 
melanogenesis. 
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Table 2. Top 15 drugs that can induce and reverse the up-regulation and down-regulation of melanogenesis 
regulatory proteins. 
S.N. Up-Regulation Down-Regulation 
Inducer Reverser Inducer Reverser 
1 Fluvoxamine Acetylsalicylic acid Acetylsalicylic acid Fluvoxamine 
2 Famotidine Prednisone Prednisone Famotidine 
3 Terbutaline Propoxycaine Propoxycaine Terbutaline 
4 Heliotrine CP-320650-01 CP-320650-01 Heliotrine 
5 Sirolimus Emetine Emetine Sirolimus 
6 Dicoumarol Dicycloverine Dicycloverine Dicoumarol 
7 Prestwick-860 Dopamine Dopamine Prestwick-860 
8 Carbimazole Cinchocaine Cinchocaine Carbimazole 
9 (-)-MK-801 Pancuronium bromide Pancuronium bromide (-)-MK-801 
10 Rilmenidine Isoetarine Isoetarine Rilmenidine 
11 Hydrastine hydrochloride Nitrendipine Nitrendipine Hydrastine hydrochloride 
12 Haloperidol Indapamide Indapamide Haloperidol 
13 Scopolamine N-oxide Ethoxyquin Ethoxyquin Scopolamine N-oxide 
14 Raubasine Amrinone Amrinone Raubasine 
15 Dihydroergocristine Folic acid Folic acid Dihydroergocristine 
Because of antiviral activity of melanin and melanogenesis based on antioxidant and 
anti-inflammatory activities, some of the recently reported inducers include (i) 7,8-
Dimethoxycoumarin, which stimulated the expression of tyrosinase, TRP-1, TRP-2, and MITF, 
thereby activating melanin production and Akt phosphorylation was increased in the Akt 
signaling pathway but interfered with the phosphorylation of ERK in the MAPKs pathway 
[85], (ii) Cistanche deserticola polysaccharide, which activated MAPK signal pathway, then 
upregulated the expression of MITF, and downstream genes TYR, TRP1, TRP2, and RAB27A 
[86], (iii) Argania Spinosa fruit shell extract, which upregulated the expression of the 
melanogenic enzymes through the cAMP-MITF signaling pathway [87], (iv) Fosfomycin 
disodium salt, which upregulated the phosphorylation of c-Jun N-terminal kinases (JNK) and 
p38 pathways [88], and (v) Dasatinib, which induced melanogenesis via ERK-CREB-MITF-
tyrosinase signaling in normal human melanocytes [89]. Inducers of melanogenesis find 
biomedical, biotechnological, and pharmaceutical applications to treat depigmentation disease 
and anti-gray hair product development.   
5. Conclusions 
 There is controversy on the interaction of melatonin with melanogenesis. Some 
researchers have reported that melatonin, and its precursor (N-acetylserotonin), inhibited 
melanogenesis in human melanotic melanoma cells in human epidermis, human MNT-1, and 
rodent [39,90,91]. In contrast, others have reported that melatonin induced melanogenesis in 
human melanoma SK-MEL-1 cells [92,93]. On the roles of inflammation factors in 
melanogenesis, Fu et al. [94] have reported that IL‑18, IL‑33, interferon‑γ, 
granulocyte‑macrophage colony-stimulating factor, prostaglandin E2 have the effect of 
promoting melanogenesis, while IL‑1, IL‑4, interleukin‑6, IL‑17, and TNF can inhibit 
melanogenesis. 
This study has reviewed melanogenesis regulation and applications of melanin as an 
antiviral chemical. Insights from the bacteria and fungi but not the virus showed negative 
implications on human melanogenesis. The proposition is that melanin is an antiviral agent. It 
downregulates dysfunctional immunological biomarker in an infectious state by specific 
viruses such as HIV-1, HIV-2, HSV-1, HCV, SV40, HAV, CV, DV, JEV, WNV, and SARS-
CoV-2. Since melanosomes could modify the cellular energy-yielding metabolism by 
switching oxidative catabolism to anaerobic glycolysis, altering the intracellular NAD/NADH 
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and NADP/NADPH ratios and/or stimulating the pentose phosphate pathway [1], defects in the 
regulation which lead to overproduction of melanin will favor cancer, while underproduction 
of melanin will favor viral infection. The antiviral activity of melanin and its complex in the 
presence of antibacterial and antifungal compounds should be investigated to further provide 
insight into the biomedical and pharmacological applications of melanin and melanogenic 
genes. 
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